{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:16Z","timestamp":1786985596300,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Genetics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.cancergen.2011.08.019","type":"journal-article","created":{"date-parts":[[2011,12,4]],"date-time":"2011-12-04T17:19:53Z","timestamp":1323019193000},"page":"536-540","source":"Crossref","is-referenced-by-count":16,"title":["Integrative genomic analysis identifies CCNB1 and CDC2 as candidate genes associated with meningioma recurrence"],"prefix":"10.1016","volume":"204","author":[{"given":"Li","family":"Bie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cancergen.2011.08.019_bib1","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(04)16153-9","article-title":"Meningiomas","volume":"363","author":"Whittle","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.cancergen.2011.08.019_bib2","series-title":"WHO classification of tumours of the central nervous system","year":"2007"},{"key":"10.1016\/j.cancergen.2011.08.019_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1006434124794","article-title":"Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy","volume":"48","author":"Hug","year":"2000","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.critrevonc.2008.01.010","article-title":"Meningioma","volume":"67","author":"Marosi","year":"2008","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/jnen\/59.7.614","article-title":"Radiation-induced meningioma: a distinct molecular genetic pattern?","volume":"59","author":"Shoshan","year":"2000","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/jnen\/60.6.628","article-title":"Chromosome 1p and 14q FISH analysis in clinicopathologic subsets of meningioma: diagnostic and prognostic implications","volume":"60","author":"Cai","year":"2001","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11060-006-9214-1","article-title":"Recurrent cytogenetic aberrations in histologically benign, invasive meningiomas of the sphenoid region","volume":"81","author":"Korshunov","year":"2007","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cancergencyto.2008.07.006","article-title":"Methylation status of MGMT gene promoter in meningiomas","volume":"187","author":"de Robles","year":"2008","journal-title":"Cancer Genet Cytogenet"},{"key":"10.1016\/j.cancergen.2011.08.019_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1750-3639.2009.00356.x","article-title":"Genomic landscape of meningiomas","volume":"20","author":"Lee","year":"2010","journal-title":"Brain Pathol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib10","doi-asserted-by":"crossref","first-page":"37865","DOI":"10.1074\/jbc.M306376200","article-title":"Degradation of cyclin B is required for the onset of anaphase in Mammalian cells","volume":"278","author":"Chang","year":"2003","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.cancergen.2011.08.019_bib11","first-page":"5113","article-title":"Cyclin B expression in HeLa cells during the G2 block induced by ionizing radiation","volume":"51","author":"Muschel","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2011.08.019_bib12","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1073\/pnas.96.5.2147","article-title":"p53 regulates a G2 checkpoint through cyclin B1","volume":"96","author":"Innocente","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cancergen.2011.08.019_bib13","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/sj.bjc.6604874","article-title":"High cyclin B1 expression is associated with poor survival in breast cancer","volume":"100","author":"Aaltonen","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cancergen.2011.08.019_bib14","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3349\/ymj.2007.48.4.694","article-title":"Prognostic implications of cyclin B1, p34cdc2, p27(Kip1) and p53 expression in gastric cancer","volume":"48","author":"Kim","year":"2007","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.cancergen.2011.08.019_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0973-1482.65242","article-title":"Expression profiling of G2\/M phase regulatory proteins in normal, premalignant and malignant uterine cervix and their correlation with survival of patients","volume":"6","author":"Saxena","year":"2010","journal-title":"J\u00a0Cancer Res Ther"},{"key":"10.1016\/j.cancergen.2011.08.019_bib16","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1158\/1078-0432.CCR-07-4159","article-title":"Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression","volume":"14","author":"de Haas","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cancergen.2011.08.019_bib17","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5858\/2000-124-0216-OOCAAC","article-title":"Overexpression of cyclin A and cyclin B1 proteins in astrocytomas","volume":"124","author":"Allan","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cancergen.2011.08.019_bib18","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A\u00a0new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cancergen.2011.08.019_bib19","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1186\/gb-2007-8-9-r183","article-title":"The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists","volume":"8","author":"Huang","year":"2007","journal-title":"Genome Biol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib20","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/0470857897.ch8","article-title":"The KEGG database","volume":"247","author":"Kanehisa","year":"2002","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.cancergen.2011.08.019_bib21","first-page":"1647","article-title":"Delayed cyclin B1 expression during the G2 arrest following DNA damage","volume":"13","author":"Maity","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.cancergen.2011.08.019_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4781(01)00204-4","article-title":"Checking out the G(2)\/M transition","volume":"1519","author":"Smits","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cancergen.2011.08.019_bib23","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0161-5890(02)00026-3","article-title":"Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53","volume":"38","author":"Yu","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0952-7915(97)80053-2","article-title":"Serological identification of human tumor antigens","volume":"9","author":"Sahin","year":"1997","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib25","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/0008-5472.CAN-03-3321","article-title":"Detection of cyclin b1 expression in g(1)-phase cancer cell lines and cancer tissues by postsorting Western blot analysis","volume":"64","author":"Shen","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cancergen.2011.08.019_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/ijc.25091","article-title":"Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort","volume":"127","author":"Nimeus-Malmstrom","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2011.08.019_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1309\/54H4Q88A1UBBWPTE","article-title":"Prognostic value of cyclin B1 protein expression in colorectal cancer","volume":"122","author":"Grabsch","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cancergen.2011.08.019_bib28","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1002\/ijc.21869","article-title":"Alteration of subcellular and cellular expression patterns of cyclin B1 in renal cell carcinoma is significantly related to clinical progression and survival of patients","volume":"119","author":"Ikuerowo","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cancergen.2011.08.019_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1365-2559.2009.03331.x","article-title":"Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer","volume":"55","author":"Cooper","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/j.cancergen.2011.08.019_bib30","first-page":"1457","article-title":"Glioma cells enhance endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1","volume":"20","author":"Zhang","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.cancergen.2011.08.019_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-7-41","article-title":"Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile","volume":"7","author":"Ducray","year":"2008","journal-title":"Mol Cancer"},{"key":"10.1016\/j.cancergen.2011.08.019_bib32","doi-asserted-by":"crossref","unstructured":"Matsuno A NH, Nagashima T, et\u00a0al. Histopathological analyses and proliferative potential of intracranial meningioma using bromodeoxyuridine and MIB-1 immunohistochemistry. Acta Histochem Cytochem 2005;38:9\u201315.","DOI":"10.1267\/ahc.38.9"},{"key":"10.1016\/j.cancergen.2011.08.019_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1440-1789.2007.00750.x","article-title":"Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma","volume":"27","author":"Bruna","year":"2007","journal-title":"Neuropathology"}],"container-title":["Cancer Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776211002390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210776211002390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T03:49:04Z","timestamp":1713152944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210776211002390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S2210776211002390"],"URL":"https:\/\/doi.org\/10.1016\/j.cancergen.2011.08.019","relation":{},"ISSN":["2210-7762"],"issn-type":[{"value":"2210-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}